# HeartMate App-Based Remote Monitoring for Cardiovascular Risk Factor Management

Study · id `cardio:ct-nct07721584` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07721584](<https://clinicaltrials.gov/study/NCT07721584>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07721584

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease; Heart failure; Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 200 participants.

## Technical summary

Registry record NCT07721584. Randomized; no masking; primary purpose prevention. Start 2026-07-14 (anticipated); primary completion 2028-06-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT07721584, source copy `cardio:ctgov-nct07721584-2026-07-23`, retrieved 2026-10-26)
- Planned start: 2026-07-14 (anticipated) (ClinicalTrials.gov record NCT07721584, source copy `cardio:ctgov-nct07721584-2026-07-23`, retrieved 2026-10-26)
- Primary completion: 2028-06-30 (anticipated) (ClinicalTrials.gov record NCT07721584, source copy `cardio:ctgov-nct07721584-2026-07-23`, retrieved 2026-10-26)
- Completion: 2028-08-31 (anticipated) (ClinicalTrials.gov record NCT07721584, source copy `cardio:ctgov-nct07721584-2026-07-23`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07721584-2026-07-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: HeartMate App-Based Remote Monitoring for Cardiovascular Risk Factor Management
- Condition: Cardiovascular Diseases
- Condition: Heart Failure, Systolic
- Condition: Coronary Artery Disease
- Condition: Heart Valve Diseases
- Condition: Peripheral Arterial Disease
- Condition: Cardiac Rehabilitation
- Condition: Cardiovascular Risk Factor
- Intervention (Device): HeartMate App-Based Remote Cardiac Rehabilitation Program
- Intervention (Device): Usual Care with HeartMate App-Based rPPG Measurement Only
- Lead sponsor: Yonsei University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Heart failure with reduced ejection fraction (HFrEF) (`cardio:hfref`)
- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: Yonsei University (`cardio:org-yonsei-university`)

## Provenance

Content hash: b853739e336a1b39afa771f7df576f6e927cc193de868a426c885dceb94861ea
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
